| Otsuka Pharmaceutical (Switzerland) GmbH - Samsca 7.5 mg, Tabletten | | 66962 | | 03 | | Samsca 7.5 mg | | Tabletten | | C03XA01 | | Tolvaptan | | 13.03.2020 | | |
| | Composition | | tolvaptanum 7.5 mg, hydroxypropylcellulosum, lactosum monohydricum 51.16 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, magnesii stearas, E 132, pro compresso. | | Packungsbestandteile | | Comprimés | | | | Principe actif | Concentr. |
|---|
| Tolvaptanum | 7.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Cellulosum Microcristallinum | | | | E 132 | | color. | | Hydroxypropylcellulosum | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Lactose Monohydrate | 51.16 mg | | | Magnesii Stearas | | | | Maydis Amylum | | | | Pro Compresso | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 10 | DDP | DDP | B | | Oui |
|
|
